Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06599749
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-23
Brief Title:
Establishment and Standardization of a Platform for In-depth Tumour Profiling TUPRO in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian Tubal or Peritoneal Origin TUPRO-Gyn
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Establishment and Standardization of a Platform for In-depth Tumour Profiling TUPRO in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian Tubal or Peritoneal Origin - a Prospective Multi-centre Human Research Ordinance Research Project Category A
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this prospective multi-centre exploratory research project is the establishment of a platform for in-depth tumour profiling in patients with advanced and metastatic High-Grade Adenocarcinoma HGAC of ovarian tubal or peritoneal origin
Detailed Description:
TUPRO-Gyn is part of the Tumour Profiler TUPRO research collaboration which aims to help generate information about patients individual tumour biology for patients with advanced malignancies using innovative biotechnologies and computational analyses for in-depth molecular profiling The TUPRO-Gyn study focuses on improving treatment for patients with advanced ovarian tubal or peritoneal cancer who often face poor outcomes and limited options after initial therapy The study aims to use advanced molecular profiling technologies to identify specific characteristics of tumors that can be targeted with personalized treatments By building a comprehensive platform for in-depth tumor analysis the project hopes to discover new biomarkers and support future clinical trials that match treatments to the molecular profile of individual tumors potentially leading to better patient outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None